Nov 2, 2018 This Week in Cardiology Nov 2, 2018 This Week in Cardiology
CV outcomes in patients with type 2 diabetes, canagliflozin, cardiorespiratory fitness, the value of randomized trials, and the most important paper of 2018 are reviewed in this week ’ s podcast.theheart.org on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
More News: Canagliflozin | Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Health | Heart | Invokana | Podcasts